DICER1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.178150E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.579590E-01
Normal-vs-Stage2
7.000900E-03
Normal-vs-Stage3
9.157600E-02
Normal-vs-Stage4
3.613600E-01
Stage1-vs-Stage2
4.976600E-01
Stage1-vs-Stage3
4.514000E-02
Stage1-vs-Stage4
7.711000E-01
Stage2-vs-Stage3
1.92946999999499E-05
Stage2-vs-Stage4
3.109200E-01
Stage3-vs-Stage4
1.395380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.262430E-02
Normal-vs-AfricanAmerican
1.592630E-01
Normal-vs-Asian
1.564240E-02
Caucasian-vs-AfricanAmerican
8.142400E-01
Caucasian-vs-Asian
1.660160E-01
AfricanAmerican-vs-Asian
3.368000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.556400E-03
Normal-vs-Female
2.615600E-02
Male-vs-Female
6.150400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.202000E-01
Normal-vs-Age(41-60Yrs)
5.946100E-02
Normal-vs-Age(61-80Yrs)
7.095200E-03
Normal-vs-Age(81-100Yrs)
8.176800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.419000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.917200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.489400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.212200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.895700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.087800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.397000E-03
Normal-vs-Daily Drinker
1.862160E-03
Normal-vs-Weekly Drinker
1.718250E-02
Normal-vs-Occasional Drinker
1.126450E-02
Normal-vs-Social Drinker
2.443800E-01
Non Drinker-vs-Daily Drinker
5.431800E-01
Non Drinker-vs-Weekly Drinker
9.158200E-01
Non Drinker-vs-Occasional Drinker
2.890400E-01
Non Drinker-vs-Social Drinker
1.302600E-01
Daily Drinker-vs-Weekly Drinker
5.549400E-01
Daily Drinker-vs-Occasional Drinker
1.103590E-01
Daily Drinker-vs-Social Drinker
7.001800E-02
Weekly Drinker-vs-Occasional Drinker
4.412800E-01
Weekly Drinker-vs-Social Drinker
1.918550E-01
Occasional Drinker-vs-Social Drinker
3.748000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.999600E-02
Normal-vs-Grade 2
8.516700E-03
Normal-vs-Grade 3
1.791550E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.556000E-01
Grade 1-vs-Grade 3
5.149400E-01
Grade 1-vs-Grade 4
4.999600E-02
Grade 2-vs-Grade 3
6.896600E-01
Grade 2-vs-Grade 4
8.516700E-03
Grade 3-vs-Grade 4
1.791550E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.204040E-03
Normal-vs-NonDiabetic
7.201600E-03
Diabetic-vs-NonDiabetic
3.917400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.978200E-04
Normal-vs-NoPancreatitis
6.216800E-03
Pancreatitis-vs-NoPancreatitis
3.015600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.900200E-02
Normal-vs-N1
7.082300E-03
N0-vs-N1
7.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.478500E-03
Normal-vs-TP53-NonMutant
9.466000E-02
TP53-Mutant-vs-TP53-NonMutant
3.802100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
